Schizophrenia is an illness that is twice as common as Alzheimer’s disease. More than two million Americans cope with this brain disease, which affects the ability to process information, organize thoughts and perceive the environment. An estimated one out of 100 people will develop schizophrenia in their lifetime.
To help raise awareness among allied medical personnel, family members of people with schizophrenia and the public, the University of North Carolina at Chapel Hill School of Medicine is sponsoring a symposium on schizophrenia, The Twelfth Annual Schizophrenia Treatment and Evaluation Program (STEP) Symposium on Saturday, May 21, 2005 at the William and Ida Friday Center at UNC, from 8:00 a.m. to 1 p.m. A breakfast buffet and lunch will be served.
Dr. Keshavan specializes in research in the neurobiology of psychosis, especially as it pertains to first episode psychotic disorders.
The title of this year’s symposium is “Early Psychosis: Recognition and Recovery”. Our special guest, Matcheri Keshavan, MD, will present the medical management of the early phases of schizophrenia. Dr. Keshavan specializes in research in the neurobiology of psychosis, especially as it pertains to first episode psychotic disorders.
For many people recovery is a fundamental goal. Diana Perkins, MD will talk about the potential benefits of early intervention and the importance of long term treatment adherence.
Bebe Smith, LCSW and David Penn, PhD will Introduce you to our new clinical program for adolescents and young adults who are in recovery from early psychosis. They will describe the mission of the program and the available services.
We request a $10 registration fee, waived upon request.
For more information or to register, contact Ellen Rothman at 919-966-0018, or email@example.com.
Media contact: Stephanie Crayton, (919) 966-2860, firstname.lastname@example.org